It is yet another obstacle in a campaign of vaccination which continuously sees stops and starts with new plans. The Johnson & Johnson vaccine is stopped for now, but the minister Speranza assures that it will be used, and could be destined, in Italy, only to the over 60s. The government will decide after the opinion of the EMA, the European drug agency. Any limitation, even if the cases under investigation in the US for abnormal clots and thrombosis are 20 with 5 deaths out of 7 million administrations, involves a change in the management of the vaccine plan.
For the future, Europe could only make deals with pharmaceutical companies that produce vaccines a Rna messenger then Moderna and Pfizer, not AstraZeneca and Johnson & Johnson. The cases, however rare, of thrombosis in the younger groups of the population, would be related to the viral vector used for the vaccine.
Just like for Astrazeneca for J&J there could be a preferential indication for the population over 60. Only this changes all plans. Until now it was thought to reserve this vaccine for the younger categories, those who will vaccinate later in time. Instead, now there would be an abundance of vaccines for the population over sixty, leaving the 50-year-olds uncovered for whom it was thought until yesterday to use the more than 7 million doses arriving from the US company by June.
Complicating is the vaccination of forty and fifty year olds that Pfizer and Moderna could have available, probably from July onwards, while for the others there could be limitations, even if not bans. The future prospect is of a seasonal vaccine, also given the resistance that seems to exist for some variants.
Added to this is the problem of the population’s lack of confidence. Some, in some regions 30%, are rejecting the AstraZeneca vaccine. There is the problem of pending doses: there are 2.3 million in total. How to use them? The model could be that of the Basilicata who works on demand: those over 60 come to the hub and have the opportunity to be vaccinated. It is a system that guarantees the greatest number of administrations in the shortest time, without the hitch of cancellations or booking problems. However, crowds are created and this is always negative with Covid around. The principle of precedence for age also falls away, older and even weaker groups of the population remain uncovered, those who are still in bed and those who cannot spend a day waiting.
In Puglia the system provides that the doses not administered at the end of the day go to the over 60s who are at the hub. There Sicily instead opted for an open day weekend with administrations for all over 60s. There are 100 thousand pending doses that can be administered on Friday, Saturday and Sunday, from 8 to 22.
They are the regions of South to move in this direction because they are those in which fewer administrations have been made. If in the rest of Italy there are 30% of doses waiting, in Basilicata there are over 50%, in Calabria 73.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
